Search

Search Results

• Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia

  Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Devika Gupta

  e2013042

  2013-06-04

  https://doi.org/10.4084/mjhid.2013.042

  2780

  PDF: 951

  HTML: 3113

  flowcytometric result of peripheral blood sample: 162

• ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS

  Junyue Cao, YuChao Sun

  e2025060

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.060

  887

  PDF: 474

  Html: 135

  Suppl. Files: 166

• CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL

  Ugo Testa, Dr. Elvira Pelosi, Dr. Germana Castelli, Dr. Alberto Fresa, Prof. Luca Laurenti

  e2024045

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.045

  3458

  PDF: 1505

  HTML: 68

• HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS

  Arturo Gonzalez Quintela, Emilio Paez-Guillan, Joaquin Campos-Franco, Rosario Alende

  e2023023

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.023

  1927

  HTML: 520

  PDF: 1160

• A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia

  Mario Biglietto, Ugo Coppetelli, Luciano Fiori, Martina Gherardini, Raffaele Maglione, Alessandro Pulsoni, Azzurra Anna Romeo

  e2025033

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.033

  849

  PDF: 688

  HTML: 173

• SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival

  Stergios Intzes, Marianthi Symeonidou, Konstantinos Zagoridis, Aikaterini Pentidou, Spanoudakis Emmanouil

  e2021006

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.006

  1991

  PDF: 803

  HTML: 203

• TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

  Luis Anibarro, Alberto Pena

  e2014026

  2014-04-06

  https://doi.org/10.4084/mjhid.2014.026

  3198

  PDF: 1215

  HTML: 8094

• ATYPICAL DIFFERENTIATION SYNDROME WITH SUDDEN VISION LOSS IN ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ATRA PLUS ATO: A CLINICAL CASE

  Eleonora Boscaro

  e2024063

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.063

  920

  PDF: 892

  HTML: 101

• THE IMPACT OF THE SARS-CoV-2 PANDEMIC ON HEALTHCARE PROVISION IN ITALY TO NON-COVID PATIENTS: A SYSTEMATIC REVIEW

  Annarita Botta, Gianmarco Lugli, Matteo Maria Ottaviani, Guido Ascione, Alessandro Bruschi, Federico Cagnazzo, Lorenzo Zammarchi, Paola Romagnani, tommaso portaluri

  e2022012

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.012

  1734

  PDF: 2345

  HTML: 346

• ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

  Mohamed L. Sorror, Rainer F. Storb

  e2010015

  2010-06-08

  https://doi.org/10.4084/mjhid.2010.015

  969

  PDF: 616

  HTML: 2201

• Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.

  Francesco Autore, Patrizia Chiusolo, Federica Sora', Luca Laurenti, Livio Pagano, Andrea Bacigalupo, Valerio De Stefano, Simona Sica

  e2023009

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.009

  1039

  PDF: 1049

  HTML: 425

• Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

  matteo molica, Fulvio Massaro, Giorgia Annechini, Erminia Baldacci, Gianna maria D'elia, Riccardo Rosati, Silvia maria trisolini, Paola Volpicelli, Robin Foà, Saveria Capria

  e2016020

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.020

  3394

  PDF: 968

  HTML: 2314

• Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis

  Fabiana Gentilini, Anna Levi, Vincenzo Federico, Eleonora Russo, Robin Foà, Maria Teresa Petrucci

  e2012035

  2012-05-07

  https://doi.org/10.4084/mjhid.2012.035

  1483

  PDF: 718

  HTML: 618

• Leukemia cutis in a patient with acute myeloid leukemia undergoing Azacitidine-Venetoclax: case presentation and review of the literature

  Elisa Buzzatti, Cristina Mauro, Caterina Botti, Roberta Presicci, Giovangiacinto Paterno, Raffaele Palmieri, Carmelo Gurnari, Flavia Mallegni, Elisa Meddi, Federico Moretti, Lucia Cardillo, Valeria Mezzanotte, Kristian Taka, Lucrezia De Marchi, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe

  e2025013

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.013

  943

  PDF: 1074

  HTML: 107

• Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited

  IOANNIS KOTSIANIDIS

  e2019045

  2019-06-25

  https://doi.org/10.4084/mjhid.2019.045

  1070

  PDF: 826

  HTML: 229

• ITPA POLYMORPHISMS AND THE INCIDENCE OF TOXICITIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  Patpetra Svasdisant, Waraporn Glomglao, Preeyanun Siraprapapat, Wiyakan Inthararujikul , Kalaya Tachavanich, Chetsada Boonthimat, Sakkarin Ardsiri, Kochpinchon Chansing, Suwimon Sriprach , Sasima Tongsai , Phakatip Sinlapamongkolkul , Kleebsabai Sanpakit , Jassada Buaboonnam

  e2023024

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.024

  972

  PDF: 886

  HTML: 338

• Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

  Daniele Derudas

  e2025025

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.025

  1475

  PDF: 1309

  HTML: 108

• Nodular lymphocyte-predominant Hodgkin lymphoma in a patient with Familial Mediterranean Fever

  Marina Belia, Asimina Papanikolaou, Panagiotis Skendros, Theodoros Vassilakopoulos

  e2022059

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.059

  938

  PDF: 488

  HTML: 271

• CLINICO-PATHOLOGICAL SPECTRUM AND NOVEL KARYOTYPIC FINDINGS IN MYELODYSPLASTIC SYNDROME: EXPERIENCE OF TERTIARY CARE CENTRE IN INDIA.

  Ruchi Gupta, Khaliqur Rahman, Manish Kumar Singh, Surabhi Kumari, Geeta yadav, Soniya Nityanand

  e2017048

  2017-08-16

  https://doi.org/10.4084/mjhid.2017.048

  1940

  PDF: 776

  HTML: 932

  Untitled: 194

• NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION

  Augustine Avilès

  e2015052

  2015-08-30

  https://doi.org/10.4084/mjhid.2015.052

  1715

  PDF: 977

  HTML: 1775

  Tables: 171

• HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

  Giuseppe Avvisati

  e2011064

  2011-12-19

  https://doi.org/10.4084/mjhid.2011.064

  13224

  PDF: 945

  HTML: 7277

• GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

  Francesco Fabozzi, Angela Mastronuzzi

  e2023032

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.032

  1868

  PDF: 489

  HTML: 521

• REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.

  Abdalla Awidi, Farah Qasem, A'sem Abu-Qamar, Batool Aqel, Rand Aladayleh, Ilham Alteerah, Ahmad Magableh, , Hisham Bawa”neh, Feras Al-fararjeh

  e2022031

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.031

  1161

  PDF: 703

  HTML: 349

• TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS

  Lanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, Federico Giannoni

  e2013072

  2013-11-19

  https://doi.org/10.4084/mjhid.2013.072

  2990

  PDF: 1008

  HTML: 3064

• Pseudo-differentiation syndrome

  Dina Khalaf, Fathi Jehani

  e2011061

  2011-12-15

  https://doi.org/10.4084/mjhid.2011.061

  1316

  PDF: 643

  HTML: 10833

  Figure 1: peripheral blood showing myeloblasts with auer rods: 108

  Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 96

  Figure 3: CXR showing pulmonary infiltartes with consolidation: 128

  Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 101

  Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 110

• Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

  Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani

  e2010035

  2010-12-13

  https://doi.org/10.4084/mjhid.2010.035

  911

  PDF: 561

  HTML: 2180

  Cover Letter: 178

• DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

  Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu

  e2023008

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.008

  1270

  PDF: 1160

  HTML: 433

• INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA

  Sutatta Supatharawanich, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Bunchoo Pongtanakul, Sasima Tongsai, Phakatip Sinlapamongkolkul, Popchai Ngamskulrungroj, Wanatpreeya Phongsamart, Kleebsabai Sanpakit , Jassada Buaboonnam

  e2021039

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.039

  2626

  PDF: 747

  HTML: 205

• HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE

  Roberto Ria, Franco Dammacco, Angelo Vacca

  e2018011

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.011

  5081

  PDF: 1598

  HTML: 1346

• Microangiopathic Hemolytic Anemia in 57-year-old woman with Borderline Serous Tumor of the Ovary:Real-Time Management of Common Pathways of Hemostatic Failure

  Gloria Joan Morris

  e2012030

  2012-05-06

  https://doi.org/10.4084/mjhid.2012.030

  1078

  PDF: 797

  HTML: 12738

• Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure

  SUPARNO CHAKRABARTI

  e2020047

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.047

  1114

  PDF: 892

  HTML: 282

• IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

  Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos

  e2012052

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.052

  3004

  PDF: 853

  HTML: 7155

  Kost Fig1: 168

  Kost Fig 2: 164

  Kost Fig3: 157

  Kost Fig 4: 174

  Kost Fig5: 172

  Kost fig 6: 158

• NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

  Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso

  e2010021

  2010-08-11

  https://doi.org/10.4084/mjhid.2010.021

  1906

  PDF: 729

  HTML: 684

• A case of severe gastrointestinal toxicity after allogeneic hematopoietic stem cell transplantation: can we improve the evaluation of the “gut fitness“ ?

  Gabriele Magliano, Enrico Morello, Mirko Farina, Vera Radici, Marco Galli, giulia brambilla, Michele Malagola, Domenico Russo, Daniele Avenoso

  e2025054

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.054

  625

  PDF: 458

  HTML: 49

• ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

  Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko

  e2018014

  2018-02-15

  https://doi.org/10.4084/mjhid.2018.014

  5210

  PDF: 1892

  HTML: 1338

• Ixazomib-associated skin exfoliation

  Yali Zhang, Long Zhao, Yuancheng Guo, bei liu

  e2022045

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.045

  804

  PDF: 518

  HTML: 190

• PROGNOSTIC SIGNIFICANCE OF TRANSCRIPT-TYPE BCR/ABL1 IN CHRONIC MYELOID LEUKEMIA

  matteo molica, elisabetta abruzzese, massimo breccia

  e2020062

  2020-09-12

  https://doi.org/10.4084/mjhid.2020.062

  3505

  PDF: 1551

  HTML: 584

• Management of meningitis caused by multi drug-resistant Acinetobacter baumannii: clinical, microbiological and pharmacokinetic results in a patient treated with colistin methanesulfonate

  Elisabetta Schiaroli, Maria Bruna Pasticci, Maria Iris Cassetta, Stefania Fallani, Corrado Castrioto, Matteo Pirro, Andrea Novelli, Lucia Henrici De Angelis, Marco Maria D'Andrea, Maria Lina Mezzatesta, Franco Baldelli, Antonella Mencacci

  e201555

  2015-10-11

  https://doi.org/10.4084/mjhid.2015.055

  2419

  PDF: 1151

  HTML: 903

  COVER LETTER: 201

• TYROSINE KINASE INHIBITORS AND INTERFERON

  Maria Dimou, Panagiotis Panagiotidis

  e2014006

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.006

  2821

  PDF: 1410

  HTML: 3041

  Cover Letter: 191

• OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

  Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz

  e2012011

  2012-02-10

  https://doi.org/10.4084/mjhid.2012.011

  1052

  PDF: 535

  HTML: 1681

  Figures: 154

  Fifures Sanz: 165

  tables Sanz: 170

  Untitled: 165

• BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

  Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini

  e2025076

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.076

  363

  PDF: 171

  Html: 38

• Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome presenting t(11;16) (q23; q24)

  Viviane Lamim Lovatel, Luize Otero, Ercole Pietro Orlando, Claudia Diniz, Filipe Vicente dos Santos-Bueno, Bruno Almeida Lopes, Elaiza Almeida Antônio de Kós, Monica Kopischitz Praxedes Lusis, Eliana Abdelhay, Teresa de Souza Fernandez

  e2022013

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.013

  1070

  PDF: 529

  HTML: 211

• CHARACTERISTICS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA IN MULTI-TRANSFUSED PATIENTS WITH THALASSEMIA MAJOR. EXPERIENCE OF A SINGLE TERTIARY CENTER.

  Nikolaos Papadopoulos, Dimitrios Kountouras, Katerina Malagari, Maria Tampaki, Maria Theochari, John Koskinas

  e2020013

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.013

  1691

  PDF: 939

  HTML: 209

• DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

  Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà

  e2018040

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.040

  3616

  PDF: 1260

  HTML: 711

  Figure 2: 437

  Figure 1: 3099

• TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL

  Giorgia Sulis, Alberto Roggi, Alberto Matteelli, Mario C. Raviglione

  e2014070

  2014-10-27

  https://doi.org/10.4084/mjhid.2014.070

  6841

  PDF: 3872

  HTML: 24862

• Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or Treated with Immunomodulatory Agents

  Alhossain A. Khalafallah, Matthias Maiwald, Amanda Cox, Burns Denise, Gerald Bates, Terry Hannan, David Seaton, Bernadene Fernandopulle, Terry Brain

  e2010005

  2010-04-20

  https://doi.org/10.4084/mjhid.2010.005

  1096

  PDF: 557

  HTML: 1128

• Pneumatosis cystoides intestinalis with fatal air embolism after minor blunt abdominal trauma in a 6-year-old girl undergoing hematopoietic stem cell trasplant: case report and review of literature

  Matteo Chinello, Olivia Chapin Arnone, Silvia Artusa, Giorgia Mazzuca, Elisa Bonetti, Virginia Vitale, Ada Zaccaron, Dario Raniero, Simone Cesaro

  e2024028

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.028

  609

  PDF: 1130

  HTML: 91

• MOLECULAR HETEROGENEITY IN ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE CENTRE EXPERIENCE FROM INDIA

  Nikhil Rabade, Goutham Raval, Shruti Chaudhary, PG Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Hasmukh Jain, Manju Sengar, Syed Hasan K, Pratibha Amare Kadam, Dhanalaxmi Shetty, Gaurav Narula, Shripad Banavali, Sumeet Gujral, Nikhil Patkar

  e2018002

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.002

  3570

  PDF: 1171

  HTML: 1072

• BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

  Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli

  e2016011

  2016-02-10

  https://doi.org/10.4084/mjhid.2016.011

  4267

  PDF: 1455

  HTML: 3604

• Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs

  Giuseppe Vittorio De Socio, Antonio D'Avolio, Alessio Sgrelli, Lorena Baietto, Lisa Malincarne, Giovanni Di Perri, Franco Baldelli

  e2012007

  2012-01-23

  https://doi.org/10.4084/mjhid.2012.007

  1560

  PDF: 762

  HTML: 800

  tile page: 148

  Table 1: 152